XTX Topco Ltd

Position in JNJ — Johnson & Johnson

CIK 1828301 LONDON, X0

Position in JNJ

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$1,304,135

-$7,702,012 QoQ

Shares Held

5,135

-86.1% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#2,748

of 4,687 holders

Holding Since

Mar 2021

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

XTX Topco Ltd holds $46,000,026 across 13 Drug Manufacturers - General names. JNJ ranks #7 (2.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	PFE	Pfizer Inc	834,735	$20,100,418
2	GILD	Gilead Sciences, Inc.	68,150	$8,610,071
3	LLY	ELI LILLY & Co	6,991	$8,385,215
4	NVO	Novo Nordisk A S	48,420	$2,321,254
5	GSK	GSK plc	35,304	$1,850,635
6	NVS	Novartis AG	11,248	$1,762,786
7	JNJ	Johnson & Johnson This page	5,135	$1,304,135
8	BIIB	Biogen Inc.	3,239	$699,818

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,304,135	5,135	-86.1%	Shares	Defined	2026-08-14
2026-03-31	$9,006,147	36,844	-39.5%	Shares	Defined	2026-05-15
2025-09-30	$11,297,455	60,929	-8.0%	Shares	Defined	2025-11-14
2025-03-31	$10,986,236	66,246	+132.4%	Shares	Defined	2025-05-08
2024-12-31	$4,123,116	28,510	+171.6%	Shares	Defined	2025-02-13
2024-09-30	$1,701,305	10,498	-43.2%	Shares	Defined	2024-11-14
2024-06-30	$2,701,913	18,486	+634.4%	Shares	Defined	2024-08-12
2023-06-30	$416,613	2,517	-80.1%	Shares	Defined	2023-08-14
2022-06-30	$2,241,773	12,629	-42.2%	Shares	Defined	2022-08-15
2022-03-31	$3,875,665	21,868	+239.7%	Shares	Defined	2022-05-13
2021-12-31	$1,101,177	6,437	-21.3%	Shares	Defined	2022-02-11
2021-09-30	$1,320,101	8,174	+30.8%	Shares	Defined	2021-11-12
2021-03-31	$1,026,694	6,247	—	Shares	Defined	2021-05-14
No filing history on record for this holder in this stock.